Trials (Jan 2024)

Preoperative supine time for adrenal venous sampling: a prospective randomized controlled trial

  • Minzhi He,
  • Yuhao Zhang,
  • Xiaoxiao Song,
  • Tianyue Zhang,
  • Hailan Yu,
  • Yongli Ji,
  • Siyuan Gong,
  • Peifei Chai,
  • Jinyi Chen,
  • Siwei Wang,
  • Bing Chen,
  • Xiaohong Xu,
  • Zhenjie Liu

DOI
https://doi.org/10.1186/s13063-023-07872-2
Journal volume & issue
Vol. 25, no. 1
pp. 1 – 9

Abstract

Read online

Abstract Background Primary aldosteronism (P.A.) is the most common form of secondary hypertension, accounting for 5% of hypertensive patients and 17–23% of patients with resistant hypertension. Compared to primary hypertension, P.A. is more prone to cause severe organ damage and even early death. Adrenal venous sampling (AVS) is a practical confirmatory test for subtyping aldosterone-producing adenoma and bilateral adrenal hyperplasia, helping physicians to make an accurate decision between surgery or medication. According to guidelines, supine in bed before AVS is recommended for a desirable result of AVS. However, investigations about the most optimal preoperative supine time before AVS are lacking. Methods/design This is a multi-center prospective randomized controlled study. One hundred twenty patients diagnosed as P.A. and willing for AVS examination will be included. Participants will be randomly allocated to a 15-min supine time group or 2-h supine time group. The primary outcome is the degree of biochemical remission (serum potassium and orthostatic ARR). The secondary outcomes are degrees of clinical remission (blood pressure, type and dose of antihypertensive drugs), the technical success rate, and the adverse event of AVS (selective index ≥ 2 is considered successful surgery without corticotropin stimulation). Discussion P.A. is an intractable public health problem, and many techniques including AVS have been developed to identify this disease correctly. This study will help to understand whether the length of preoperative supine time would affect the diagnostic efficacy of AVS and thus help to formulate a more reasonable AVS procedure. Trial registration ClinicalTrials.gov NCT05658705. Registered on 10 September 2022.

Keywords